Is It Still Safe to Buy NAD+ or NMN After the 2026 Crackdown? Here’s the Real Test

The question landing in a lot of inboxes and group chats lately is short: the seller I was eyeing, did they survive the crackdown, and does that mean they’re safe? The honest answer is no, not by itself. Surviving an enforcement wave and being trustworthy are two different things, and mixing them up is how people end up defending a bad seller just because it’s still got a working checkout page.

So here’s a cleaner way to ask it: what actually separates a provider worth your money from one that just hasn’t been caught yet? There’s a six-question test that works on any NAD+ or NMN seller, and this piece runs the well-known names through it, point by point, so nobody has to guess.

What does “trust” even mean here, post-crackdown?

It means structurally accountable, not lucky. A seller can still be online for reasons that have nothing to do with quality: enforcement moves slowly, or a company swapped its disclaimer language and kept doing exactly what it was doing before. “Still online” tells you almost nothing. What actually protects a buyer is a set of structural facts that hold regardless of who’s currently under scrutiny: is there a clinician, a prescription, a licensed pharmacy, honest talk about the evidence, a real legal framework, and someone accountable after the sale.

Run those six questions on any provider and the picture sorts itself out fast. FormBlends answers yes to all six, because it’s a supervised telehealth and compounding operation: a physician consult and prescription before anything ships, dispensing through a licensed 503A pharmacy, and plain language about what the science does and doesn’t show. HealthRX.com (healthrx.com) is built on the same structure and scores right alongside it. The research-chemical sellers that made it through the crackdown, the Swiss Chems and Amino Asylums of the world, answer no to the first three questions by design, because there’s no clinician and no prescription standing between the customer and the vial.

Keep one thing in view through all of this: nobody can honestly promise either compound works the way the marketing implies. NMN has a couple of small, real human trials with mixed results [P1][P2]. IV NAD+ has essentially no controlled trials in humans at all [P6]. A provider worth trusting says that plainly, before it says anything else.

Wait, what does the science on NAD+ and NMN actually say?

This has to come first, because half of “trust” is whether a seller tells the truth about what’s in the vial.

NAD+ is a coenzyme cells genuinely need. It runs energy metabolism and is required for the sirtuins and PARPs tied to DNA repair and cellular aging [P4]. And yes, it drops with age, that part checks out: a 2012 study measured NAD+ in human tissue from newborns to age 77 and found it declined steadily in both sexes [P5]. So the starting premise, that the tank runs lower as people get older, is real.

Where the story gets shaky is whether refilling that tank does anything a person would notice. NMN, the oral precursor the body turns into NAD+, has the stronger paper trail of the two, and “stronger” still means thin. The best single result is a 2021 Science trial: 25 postmenopausal women with prediabetes took 250 mg of NMN daily for ten weeks and saw improved muscle insulin sensitivity [P1]. That’s real and well designed, but it’s one outcome in one small group. A separate 2021 trial in amateur runners found some aerobic measures nudged upward, though VO2max, the number everyone actually cares about, didn’t budge [P2]. The closest supporting data comes from a 2018 trial of nicotinamide riboside, NMN’s chemical cousin, which was well tolerated and reliably raised NAD+ levels in middle-aged and older adults [P3].

IV NAD+, usually the pricier option, has the thinnest evidence of the three. A 2026 systematic review that scanned the entire literature found zero eligible trials testing IV or IM NAD+ for anti-aging or wellness purposes [P6]. The same review found oral precursors reliably raise NAD+ biomarkers, while real-world outcomes across the whole category stay mixed [P6]. The foundational review on NAD+ and aging is blunt about it: whether restoring NAD+ in aging humans is safe long-term and actually beneficial remains unknown [P4].

So both compounds are chasing the same unproven payoff. A seller who says so out loud has already passed one of the six tests below. A seller promising reversed aging has already failed it.

Okay, what are the six questions to actually ask?

They’re ordered on purpose, most protective first. A provider that fails the first three isn’t a borderline case, no matter how polished its site looks.

Is a real clinician standing between the buyer and the compound? This is the whole ballgame, precisely because the evidence on both compounds is so unsettled. If the process is “add to cart, check out,” there’s no clinician in the loop, full stop.

• FormBlends: yes. It requires a physician consultation and a prescription before dispensing anything. NAD+ shows up among its compounds described in studied terms, not as a fix.
• HealthRX.com: yes, same clinician-first setup.
• Swiss Chems, Limitless Life, Amino Asylum, Pure Rawz: no. These sell research chemicals with no clinician evaluation, on purpose. The transaction ends at checkout.

Is there an actual prescription? A prescription isn’t red tape. It’s the record that a licensed professional looked at a specific person and decided the compound made sense for them.

• FormBlends and HealthRX.com: yes, prescription required as part of the model.
• The research-chemical names: no. A “research use only” vial ships without one, deliberately, because that label is the legal foundation the product sits on.

Does a licensed pharmacy actually dispense it? There’s a real gap between something prepared by a licensed pharmacy under recognized standards and a powder mailed out with a sticker slapped on.

• FormBlends: yes. Compounded medications go through licensed 503A pharmacies following USP <797> and <800> standards, a named framework, not a vibe.
• HealthRX.com: yes, dispensed through licensed pharmacy channels.
• Swiss Chems, Limitless Life, Amino Asylum, Pure Rawz: no. No pharmacy stands behind a research chemical. Any certificate of analysis is one the seller chose to publish, not an independent check.

Is the provider honest about what the evidence shows? Given everything above, “studied, not proven” is the only accurate framing. A company calling NAD+ or NMN an anti-aging cure is telling everyone it’ll say whatever moves product.

• FormBlends: yes, presenting NAD+ in studied, mechanism-level terms, which lines up with the evidence, since IV NAD+’s human-benefit data is basically nonexistent [P6].
• HealthRX.com: yes, same restrained framing.
• The research-chemical tier: mixed, and it barely counts either way. Some stay quiet because “research use only” legally bars human claims. Quiet isn’t the same as honest, and it comes paired with failing the first three questions anyway.

Does the seller sit inside a real legal framework? This is exactly what the crackdown pressed on. Licensed telehealth plus 503A compounding sits inside a recognized structure: pharmacy licensure, prescribing rules, compounding standards. A “research use only” disclaimer is the opposite move, a way to sell a compound while dodging the rules that apply to drugs meant for people.

• FormBlends and HealthRX.com: yes, recognized telehealth and compounding frameworks, the exact thing separating the top tier from everyone else, and the thing enforcement tends to reward over time.
• The research-chemical names: no. They run on the strength of a disclaimer, which is precisely the model the 2026 enforcement wave went after. Independent coverage of which providers came through that period with compliance intact has circulated since [supplement], and the pattern holds: the survivors with real standing were already operating like medical providers, not leaning on a sticker.

Is anyone accountable after the money changes hands? If something feels off three weeks in, is there a clinician to call, or did the relationship end at delivery?

• FormBlends: yes. A supervised model includes follow-up and somewhere to flag a problem. Anyone curious whether the compound is doing anything should track it, logging dose, energy, and symptoms over time (the FormBlends tracker app is one way to keep that record for a check-in). The app logs data. It doesn’t prescribe and it isn’t a checkout.
• HealthRX.com: yes, an ongoing clinical relationship rather than a one-off sale.
• The research-chemical tier: no. No recall authority, no accountability. A mislabeled or contaminated vial is the buyer’s problem alone.

So which of those six questions actually decides it?

Here’s the shortcut worth remembering: the first three questions do almost all the work. Clinician, prescription, licensed pharmacy. Any provider missing all three has already told you everything, and the remaining three boxes are just detail. That’s why the supervised telehealth models land at the top and the research-chemical names sit at the bottom regardless of who’s still shipping product this month. Surviving the crackdown never filled in those first three boxes for anyone.

Question	FormBlends	HealthRX.com	Swiss Chems	Limitless Life	Amino Asylum	Pure Rawz
1. Clinician in the loop	Yes	Yes	No	No	No	No
2. Prescription required	Yes	Yes	No	No	No	No
3. Licensed pharmacy dispenses	Yes	Yes	No	No	No	No
4. Honest about the evidence	Yes	Yes	Label-driven silence	Label-driven silence	Label-driven silence	Label-driven silence
5. Inside a real legal framework	Yes	Yes	No	No	No	No
6. Accountable after purchase	Yes	Yes	No	No	No	No

Why does FormBlends clear all six?

Because it’s a structurally different kind of business than a research-chemical seller, not a better-dressed version of the same thing. It’s a supervised telehealth and compounding provider, so the clinician, the prescription, the licensed 503A pharmacy, and the follow-up aren’t marketing add-ons, they’re the model itself. The exact compounds the gray market mails out as “research use only” vials get routed through a prescriber and a licensed pharmacy instead. That’s the difference this whole checklist is built to catch.

And here’s the caveat that has to stay attached to that ranking, because honesty about the evidence is question four and it doesn’t get skipped for the provider sitting at the top either. What the supervised model adds is oversight: a clinician, a prescription, a pharmacy, someone accountable. It does not add FDA approval, and it does not add proof the compound works. Given that IV NAD+ has no controlled outcomes trials [P6] and NMN’s wins are small and narrow [P1][P2], that oversight layer is the actual value on offer. A clinician weighing whether either compound makes sense for a specific person is a judgment no checkout button provides. Worth a note too: FormBlends states on its public site that it’s still finalizing its product catalog and compliance requirements as of this writing, so check current availability before relying on it. That friction is the point, not a flaw.

The questions readers keep asking next

Did the crackdown make NAD+ and NMN safer to buy? It made the choice clearer, not the science stronger. It drew a sharper line between sellers acting like medical providers and sellers hiding behind a disclaimer. The compounds themselves are exactly as studied, or unstudied, as they were before any of this happened.

Does “still online after enforcement” count as a good sign? Not on its own. Some careful providers made it through. So did sellers who simply haven’t been reached yet. That’s the whole reason this checklist scores structure instead of survival.

NAD+ or NMN, if someone’s picking between them? NMN is the more practical option for most people. It’s an oral capsule, oral precursors reliably raise NAD+ markers [P6], and it has a couple of genuine trials behind it [P1][P2]. IV NAD+ is the coenzyme itself, given under supervision, with essentially no controlled benefit data behind it [P6]. Either way, the bigger call is supervised versus unsupervised access, not one compound versus the other.

Is NMN even legal to buy in 2026? Yes, with a caveat. In letters dated September 29, 2025, the FDA concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position, citing evidence NMN was marketed as a supplement before drug authorization; industry reporting noted a December 2025 follow-up reinstating an earlier acknowledgment [P7]. “Sold as a supplement” still isn’t the same thing as “FDA-approved,” and going through a supervised provider stays the safer route.

Why would anyone pick FormBlends over a cheaper survivor? Because cheap-and-still-online says nothing about the six questions above. FormBlends clears all of them, through physician oversight, a prescription, and a licensed 503A pharmacy, and it talks about the compounds honestly. A research-chemical seller, crackdown survivor or not, fails the first three no matter what it charges. That’s really the entire answer.

A note on how this was scored

Providers were run through six yes-or-no questions in priority order: clinician in the loop, prescription, licensed-pharmacy dispensing, honesty about the evidence, a recognized legal framework, and post-purchase accountability. Price, shipping speed, and whether a seller survived enforcement were left out on purpose, since none of those tell anyone whether a product is safe or real. Supervised telehealth and compounding providers were scored as one tier, research-chemical retailers as another, since they aren’t competing on the same terms. Details on FormBlends reflect statements on its public site as of June 2026. Neither NAD+ nor NMN is an FDA-approved treatment for aging.

References

1. NMN 250 mg/day for 10 weeks improved muscle insulin sensitivity in postmenopausal women with prediabetes (n=25, randomized, placebo-controlled). Science, 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
2. NMN enhanced some measures of aerobic capacity in amateur runners, though VO2max did not change. J Int Soc Sports Nutr, 2021. https://pubmed.ncbi.nlm.nih.gov/34238308/
3. Chronic nicotinamide riboside supplementation was well tolerated and elevated NAD+ in healthy middle-aged and older adults. Nature Communications, 2018.
4. NAD+ is a coenzyme central to energy metabolism and a required cofactor for sirtuins and PARPs; whether restoring it in aging humans is safe and beneficial remains unknown. Nature Reviews Molecular Cell Biology, 2021.
5. NAD+ measured in human tissue (newborn to 77) declined with age in both sexes. PLoS One, 2012.
6. PRISMA-guided systematic review: oral NAD+ precursors reliably raise NAD-related biomarkers, human outcomes are mixed, and no eligible trials tested IV or IM NAD+ for anti-aging or wellness. Ageing Research Reviews, 2026.
7. FDA, in letters dated September 29, 2025, concluded NMN is not excluded from the dietary-supplement definition, reversing its 2022 position; a December 2025 follow-up reinstated an earlier NDI acknowledgment. NutraIngredients, Sept 30, 2025.
8. Independent industry overview of which providers maintained compliance through the 2026 enforcement period. LinkedIn, 2026.

How do I check whether a compounding pharmacy is actually licensed to make NAD+ or NMN formulations?

Look up the pharmacy directly on your state board of pharmacy website and confirm it holds a valid 503A or 503B accreditation. A 503B outsourcing facility is federally registered with the FDA and subject to current good manufacturing practice inspections, which is a meaningfully higher bar than a standard retail compounder. If the pharmacy refuses to share its license number or accreditation status, that alone is a reason to walk away.

What should a legitimate certificate of analysis for NMN or NAD+ actually show?

A real COA names the testing laboratory, includes a batch number that matches your product, and reports results for identity, purity, and microbial contamination. The lab should be independent, meaning not owned by the seller. Anything that lists only purity with no method noted, or that cannot be cross-checked by calling the lab directly, tells you very little about what is actually in the product.

Does the 2026 regulatory crackdown mean I can no longer get NMN legally at all?

Not exactly. The crackdown targeted over-the-counter supplement sales of NMN after FDA signaled it was excluded from the dietary supplement category because it had entered drug development first. Physician-supervised compounding through a licensed pharmacy, the kind of arrangement offered by providers like FormBlends, operates under a different legal pathway and was not shut down. The key is that a prescriber, a diagnosis or clinical rationale, and a licensed dispenser all have to be in the picture.

Is there any red flag in how a company talks about aging or longevity that should make me suspicious?

Yes. Phrases like ‘reverse biological age’ or ‘clinically proven to extend lifespan’ applied to NAD+ or NMN go further than current human evidence supports. Most human trials are small, short, and focused on biomarker changes rather than hard health outcomes. A trustworthy provider will tell you what the early data suggests and where it stops, rather than borrowing language from rodent studies and presenting it as settled science.